Dennis Earle

627 total citations
13 papers, 442 citations indexed

About

Dennis Earle is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Dennis Earle has authored 13 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Psychiatry and Mental health and 5 papers in Oncology. Recurrent topics in Dennis Earle's work include Hormonal and reproductive studies (6 papers), Sexual function and dysfunction studies (6 papers) and Hypothalamic control of reproductive hormones (3 papers). Dennis Earle is often cited by papers focused on Hormonal and reproductive studies (6 papers), Sexual function and dysfunction studies (6 papers) and Hypothalamic control of reproductive hormones (3 papers). Dennis Earle collaborates with scholars based in United States and Australia. Dennis Earle's co-authors include L E Diamond, Perry B. Molinoff, R. Rosen, A. M. Shadiack, Michael S. Willett, Carl Spana, Check Y. Quon, Lisa E. Diamond, Michael A. Perelman and Raymond C. Rosen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Dennis Earle

13 papers receiving 415 citations

Peers

Dennis Earle
Johna Lucas United States
K Suchecka-Rachoń Poland
F. Giuliano France
Regula E. Bürki United States
Sudip Chakravarti United Kingdom
Raquel Corripio Spain
Sabine Naessén Sweden
Katrina Evers Switzerland
Srdjan Popović Serbia
Akmal Taher Indonesia
Johna Lucas United States
Dennis Earle
Citations per year, relative to Dennis Earle Dennis Earle (= 1×) peers Johna Lucas

Countries citing papers authored by Dennis Earle

Since Specialization
Citations

This map shows the geographic impact of Dennis Earle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Earle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Earle more than expected).

Fields of papers citing papers by Dennis Earle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Earle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Earle. The network helps show where Dennis Earle may publish in the future.

Co-authorship network of co-authors of Dennis Earle

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Earle. A scholar is included among the top collaborators of Dennis Earle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Earle. Dennis Earle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nordstrom, Beth, Melissa Hamilton, Jenna Collins, et al.. (2022). Treatment Patterns and Outcomes Following Disease Progression on Anti-PD-1 Therapies for Advanced Melanoma. Future Oncology. 18(11). 1343–1355. 2 indexed citations
2.
3.
Jurcic, Joseph G., Farhad Ravandi, John M. Pagel, et al.. (2015). Phase I trial of α-particle therapy with actinium-225 (225Ac)-lintuzumab (anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML.. Journal of Clinical Oncology. 33(15_suppl). 7050–7050. 20 indexed citations
4.
5.
6.
Hallam, Trevor J., Carl Spana, Dennis Earle, Annette M. Shadiack, & Shubh D. Sharma. (2007). Melanocortins in the Treatment of Male and Female Sexual Dysfunction. Current Topics in Medicinal Chemistry. 7(11). 1137–1144. 40 indexed citations
7.
Althof, Stanley E., Michael A. Perelman, Raymond C. Rosen, Steven Fischkoff, & Dennis Earle. (2007). 1041: Improvement in Sexual Relationship Satisfaction, Confidence, and Self-Esteem in Erectile Dysfunction Patients Treated with Bremelanotide. The Journal of Urology. 177(4S). 344–345. 2 indexed citations
8.
Diamond, Lisa E., Dennis Earle, Julia R. Heiman, et al.. (2006). An Effect on the Subjective Sexual Response in Premenopausal Women with Sexual Arousal Disorder by Bremelanotide (PT-141), a Melanocortin Receptor Agonist. The Journal of Sexual Medicine. 3(4). 628–638. 75 indexed citations
9.
Diamond, L E, Dennis Earle, Wilson García, & Carl Spana. (2005). Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology. 65(4). 755–759. 32 indexed citations
10.
Rosen, R., L E Diamond, Dennis Earle, A. M. Shadiack, & Perry B. Molinoff. (2004). Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra®. International Journal of Impotence Research. 16(2). 135–142. 67 indexed citations
11.
Line, Bruce R., Richard J. Breyer, Karen D. McElvany, Dennis Earle, & M.B. Khazaeli. (2004). Evaluation of human anti-mouse antibody response in normal volunteers following repeated injections of fanolesomab (NeutroSpec), a murine anti–CD15 IgM monoclonal antibody for imaging infection. Nuclear Medicine Communications. 25(8). 807–811. 11 indexed citations
12.
Diamond, L E, Dennis Earle, R. Rosen, Michael S. Willett, & Perry B. Molinoff. (2004). Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. International Journal of Impotence Research. 16(1). 51–59. 91 indexed citations
13.
Molinoff, Perry B., A. M. Shadiack, Dennis Earle, L E Diamond, & Check Y. Quon. (2003). PT‐141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction. Annals of the New York Academy of Sciences. 994(1). 96–102. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johna Lucas Breakdown of academic impact, for papers by K Suchecka-Rachoń Breakdown of academic impact, for papers by F. Giuliano Breakdown of academic impact, for papers by Regula E. Bürki Breakdown of academic impact, for papers by Sudip Chakravarti Breakdown of academic impact, for papers by Raquel Corripio Breakdown of academic impact, for papers by Sabine Naessén Breakdown of academic impact, for papers by Katrina Evers Breakdown of academic impact, for papers by Srdjan Popović Breakdown of academic impact, for papers by Akmal Taher
Rankless by CCL
2026